全文获取类型
收费全文 | 1763篇 |
免费 | 102篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 151篇 |
妇产科学 | 21篇 |
基础医学 | 197篇 |
口腔科学 | 47篇 |
临床医学 | 163篇 |
内科学 | 409篇 |
皮肤病学 | 26篇 |
神经病学 | 48篇 |
特种医学 | 490篇 |
外科学 | 112篇 |
综合类 | 28篇 |
预防医学 | 54篇 |
眼科学 | 18篇 |
药学 | 56篇 |
中国医学 | 3篇 |
肿瘤学 | 63篇 |
出版年
2022年 | 5篇 |
2021年 | 9篇 |
2020年 | 10篇 |
2019年 | 9篇 |
2018年 | 19篇 |
2017年 | 12篇 |
2016年 | 22篇 |
2015年 | 30篇 |
2014年 | 28篇 |
2013年 | 62篇 |
2012年 | 33篇 |
2011年 | 35篇 |
2010年 | 77篇 |
2009年 | 66篇 |
2008年 | 38篇 |
2007年 | 28篇 |
2006年 | 34篇 |
2005年 | 24篇 |
2004年 | 16篇 |
2003年 | 20篇 |
2002年 | 27篇 |
2001年 | 24篇 |
2000年 | 28篇 |
1999年 | 27篇 |
1998年 | 136篇 |
1997年 | 119篇 |
1996年 | 127篇 |
1995年 | 97篇 |
1994年 | 76篇 |
1993年 | 82篇 |
1992年 | 24篇 |
1991年 | 23篇 |
1990年 | 17篇 |
1989年 | 60篇 |
1988年 | 44篇 |
1987年 | 50篇 |
1986年 | 48篇 |
1985年 | 47篇 |
1984年 | 25篇 |
1983年 | 31篇 |
1982年 | 34篇 |
1981年 | 20篇 |
1980年 | 36篇 |
1979年 | 15篇 |
1978年 | 15篇 |
1977年 | 17篇 |
1976年 | 23篇 |
1975年 | 25篇 |
1971年 | 5篇 |
1966年 | 3篇 |
排序方式: 共有1887条查询结果,搜索用时 15 毫秒
71.
HUBERT COCHET M.D. YUKI KOMATSU M.D. FREDERIC SACHER M.D. AMIR SHERWAN JADIDI M.D. DANIEL SCHERR M.D. MATTHIEU RIFFAUD M.D. NICOLAS DERVAL M.D. ASHOK SHAH M.D. LAURENT ROTEN M.D PATRIZIO PASCALE M.D. JATIN RELAN Ph.D. MAXIME SERMESANT Ph.D. NICHOLAS AYACHE Ph.D. MICHEL MONTAUDON M.D. Ph.D. FRANÇOIS LAURENT M.D. MÉLÈZE HOCINI M.D. MICHEL HAÏSSAGUERRE M.D. PIERRE JAÏS M.D. Ph.D . 《Journal of cardiovascular electrophysiology》2013,24(4):419-426
MDCT/MRI Fusion for the Guidance of VT Ablation . Background: Delayed enhancement (DE) MRI can assess the fibrotic substrate of scar‐related VT. MDCT has the advantage of inframillimetric spatial resolution and better 3D reconstructions. We sought to evaluate the feasibility and usefulness of integrating merged MDCT/MRI data in 3D‐mapping systems for structure–function assessment and multimodal guidance of VT mapping and ablation. Methods: Nine patients, including 3 ischemic cardiomyopathy (ICM), 3 nonischemic cardiomyopathy (NICM), 2 myocarditis, and 1 redo procedure for idiopathic VT, underwent MRI and MDCT before VT ablation. Merged MRI/MDCT data were integrated in 3D‐mapping systems and registered to high‐density endocardial and epicardial maps. Low‐voltage areas (<1.5 mV) and local abnormal ventricular activities (LAVA) during sinus rhythm were correlated to DE at MRI, and wall‐thinning (WT) at MDCT. Results: Endocardium and epicardium were mapped with 391 ± 388 and 1098 ± 734 points per map, respectively. Registration of MDCT allowed visualization of coronary arteries during epicardial mapping/ablation. In the idiopathic patient, integration of MRI data identified previously ablated regions. In ICM patients, both DE at MRI and WT at MDCT matched areas of low voltage (overlap 94 ± 6% and 79 ± 5%, respectively). In NICM patients, wall‐thinning areas matched areas of low voltage (overlap 63 ± 21%). In patients with myocarditis, subepicardial DE matched areas of epicardial low voltage (overlap 92 ± 12%). A total number of 266 LAVA sites were found in 7/9 patients. All LAVA sites were associated to structural substrate at imaging (90% inside, 100% within 18 mm). Conclusion: The integration of merged MDCT and DEMRI data is feasible and allows combining substrate assessment with high‐spatial resolution to better define structure–function relationship in scar‐related VT. (J Cardiovasc Electrophysiol, Vol. 24, pp. 419‐426, April 2013) 相似文献
72.
Diastole, that portion of the cardiac cycle that begins with isovolumic relaxation and ends with mitral valve closure, results in ventricular filling and involves both active (energy-dependent) and passive processes. The interactions between active processes (myocardial relaxation) that primarily influence early ventricular filling and passive processes, such as loading conditions, myocardial compliance, and valvular disease, are complex. Clinical methods to assess ventricular filling include cardiac catheterization, radionuclide angiography, and echocardiography. Any measurements of diastolic function must be made with an understanding of the determinants of ventricular filling and the limitations of the diagnostic test. Many cardiac disorders are characterized by elevated pulmonary venous pressures in the face of normal systolic ventricular function, which suggests a primary abnormality of diastolic function. Abnormalities in diastolic function have been observed in coronary artery disease, congestive heart failure (with and without systolic dysfunction), hypertrophic cardiomyopathy, hypertension, and in healthy elderly subjects. Identification of these abnormalities may be useful clinically, particularly in patients with symptoms of heart failure and normal systolic function. Data are not available to determine the optimal therapy for such patients, although evidence suggests that calcium channel blockers, beta blockers, and agents that reverse myocardial hypertrophy may be useful. This review briefly summarizes the physiology of diastole, the methods of clinical assessment of diastolic function, and the role of diastolic function in cardiovascular disease. 相似文献
73.
Barbara Uhl Katharina T Prochazka Karoline Fechter Katrin Pansy Hildegard T Greinix Peter Neumeister Alexander JA Deutsch 《World journal of gastrointestinal oncology》2022,14(1):153-162
Approximately 8% of all non-Hodgkin lymphomas are extranodal marginal zone B cell lymphomas of mucosa-associated lymphoid tissue (MALT), also known as MALT lymphomas. These arise at a wide range of different extranodal sites, with most cases affecting the stomach, the lung, the ocular adnexa and the thyroid. The small intestine is involved in a lower percentage of cases. Lymphoma growth in the early stages is associated with long-lasting chronic inflammation provoked by bacterial infections (e.g., Helicobacter pylori or Chlamydia psittaci infections) or autoimmune conditions (e.g., Sjögren’s syndrome or Hashimoto thyroiditis). While these inflammatory processes trigger lymphoma cell proliferation and/or survival, they also shape the microenvironment. Thus, activated immune cells are actively recruited to the lymphoma, resulting in either direct lymphoma cell stimulation via surface receptor interactions and/or indirect lymphoma cell stimulation via secretion of soluble factors like cytokines. In addition, chronic inflammatory conditions cause the acquisition of genetic alterations resulting in autonomous lymphoma cell growth. Recently, novel agents targeting the microenvironment have been developed and clinically tested in MALT lymphomas as well as other lymphoid malignancies. In this review, we aim to describe the composition of the microenvironment of MALT lymphoma, the interaction of activated immune cells with lymphoma cells and novel therapeutic approaches in MALT lymphomas using immunomodulatory and/or microenvironment-targeting agents. 相似文献
74.
75.
76.
Marvin A. Konstam Joseph A. Hill Richard J. Kovacs Robert A. Harrington James A. Arrighi Amit Khera 《Journal of the American College of Cardiology》2017,69(10):1305-1312
Academic medical centers (AMCs) are presently facing enormous challenges arising from a prospective decline in government funding for research and education, shifting payment models emphasizing efficiency and value, and increasing competition. Left unabated, these challenges will drive many AMCs to de-emphasize or forsake their core missions in an effort to survive. Stemming from a symposium held at the 2015 Scientific Sessions of the American College of Cardiology titled, “The Academic Medical Center of the Future,” we propose a series of changes, including internal restructuring, system-wide partnership, and novel approaches to support research and education, that are designed to better position AMCs to compete and face their growing challenges in a manner that preserves their essential missions. In aggregate, these changes will facilitate establishing the academic medical system of the future. 相似文献
77.
Raymond R. Russell MD PhD FASNC Brian G. Abbott MD FASNC James A. Arrighi MD FASNC Ron Blankstein MD Mylan C. Cohen MD MPH FASNC Tracy L. Faber PhD John J. Mahmarian MD FASNC Edward J. Miller MD PhD Leslee Shaw PhD FASNC Prem Soman PhD MD FASNC Mark I. Travin MD FASNC 《Journal of nuclear cardiology》2011,18(1):177-184
78.
79.
80.
Dios Castro E Maquet Dusart JA 《Archivos de la Sociedad Espa?ola de Oftalmología》2000,75(11):775-778
PURPOSE/METHOD: We present a case of a patient who developed recurrent epithelial herpes simplex keratitis after starting treatment with latanoprost. Her ophthalmic history was only remarkable for a past episode of herpetic keratitis 21 years previously. RESULTS/CONCLUSIONS: Episodes of herpetic keratitis were under remission only when latanoprost was discontinued. No recurrences of herpes simplex keratitis have been observed since then. Latanoprost usage might be associated with recurrent episodes of herpes simplex keratitis in patients with previous history of ocular herpes simplex virus infection. 相似文献